MOUNTAIN VIEW, CA / ACCESS Newswire / May 13, 2025 / AbTherx, Inc., a biotechnology company with innovative transgenic technologies that simplify and accelerate antibody discovery, today announced a ...

Renier Brentjens, MD, PhD, one of the pioneers in the development of chimeric antigen receptor (CAR) T-cell therapy, is poised to see the technology take its next big leap, with researchers testing ...

Advanced Cell Technology Inc. wins $25 million commitment from investment firm Socius Capital Group. Advanced Cell Technology Inc. (OTC:ACTC) secured a $25 million investment to support clinical ...

In 2024, the market share for n-type cell technology surpassed that for p-type cells for the first time, with p-PERC cells quickly exiting the stage. N-TOPCon cells have emerged as the mainstream ...

Losses at Advanced Cell Technology (ACT) of Marlborough deepened in its first quarter, as the cost of clinical trials for its macular degeneration treatments rose, the company said. Advanced Cell ...